GL1X · GenesisL1 explorer

Research workbench

Human inositol (1,4,5)-trisphosphate 3-kinase substituted with selenomethionine

Analyse Human inositol (1,4,5)-trisphosphate 3-kinase substituted with selenomethionine in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1W2F
Type
protein
Length
548 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Inositol-trisphosphate 3-kinase a
EC
2.1.7.127
UniProt
P23677
Ligands
SO4
Pockets
4 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInositol-trisphosphate 3-kinase a (EC 2.1.7.127)protein27640% helix, 22% strandP23677
BInositol-trisphosphate 3-kinase a (EC 2.1.7.127)protein27242% helix, 23% strandP23677

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18310.690.7690SO4
22280.530.7731empty
31000.370.7519empty
4890.330.7418empty

Interfaces

1 interface between chains.

  • A–B · 919 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 modified (engineered).

Compared structures

  • 1W2F · Human Inositol (1,4,5)-trisphosphate 3-kinase substituted with selenomethionine · the same entry in another collection · chain A against A, TM-score 1.00
  • P23677 · AlphaFold monomer V2.0 prediction for inositol-trisphosphate 3-kinase a (P23677) · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.